✦ LIBER ✦

Sorafenib for non-selected patient population with advanced hepatocellular carcinoma: efficacy and safety data according to liver function

✍ Scribed by Jon Zugazagoitia, Aránzazu Manzano, Javier Sastre, Jose María Ladero, Javier Puente, Eduardo Díaz-Rubio

Book ID: 118822794
Publisher: Springer Milan
Year: 2012
Tongue: Spanish
Weight: 299 KB
Volume: 15
Category: Article
ISSN: 1699-048X
DOI: 10.1007/s12094-012-0902-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of sorafenib in pati

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia–Pacific trial

✍ Ann-Lii Cheng; Zhongzhen Guan; Zhendong Chen; Chao-Jung Tsao; Shukui Qin; Jun Su 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 553 KB

P.08.17 SAFETY AND TOLERABILITY OF SORAF

P.08.17 SAFETY AND TOLERABILITY OF SORAFENIB TREATMENT FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH SEVERE IMPAIRMENT OF LIVER FUNCTION: A PROSPECTIVE STUDY

✍ A.L. Inghilesi; D. Gallori; L. Antonuzzo; F. Pasquinelli; U. Arena; G. Laffi; F. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

The use of single-agent sorafenib in the

The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis : A retrospective analysis of efficacy, safety, and survival benefits

✍ Joanne Chiu; Yuen Fong Tang; Tzy-Jyun Yao; Ashley Wong; Hilda Wong; Roland Leung 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 792 KB

226 EFFICACY AND SAFETY OF SORAFENIB AT

226 EFFICACY AND SAFETY OF SORAFENIB AT LONG TERM IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): NEED TO SCREEN FOR CARDIOVASCULAR EVENTS AFTER LONG TERM ADMINISTRATION

✍ M. Reig; A. Forner; C. Rodriguez de Lope; J. Rimola; S. Tremosini; C. Mestres; C 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Percutaneous ablation procedures in cirr

Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence

✍ Maurizio Pompili; Vincenzo Giorgio Mirante; Gianfranco Rondinara; Luigi Rainero 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 1 views

Aims of this retrospective study were to analyze the efficacy and safety of percutaneous ethanol injection (PEI) and radiofrequency ablation (RFA) in cirrhotic patients with hepatocellular carcinoma (HCC) submitted to orthotopic liver transplantation (OLT). We studied 40 patients undergoing OLT in w